US 8034821
Selective serine/threonine kinase inhibitors
granted A61PA61P35/00
Quick answer
US patent 8034821 (Selective serine/threonine kinase inhibitors) held by The Regents of the University of California expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00